Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
NYU Langone Health
With
National Institutes of Health (NIH)
Age
18–any
Sex
FEMALE
Healthy volunteers
Accepted
You may be eligible if
Women with no sign of breast cancer as controls
Non-pregnant and non-lactating
Ability to understand and willingness to sign a written consent
You may not be if
Contra-indications to MRI (i.e., ferromagnetic prostheses, metallic surgical implants that are not compatible with an MRI machine, claustrophobia etc.)
Medical condition such as uncontrolled infection (including HIV), uncontrolled diabetes mellitus or cardiac disease which, in the opinion of the treating physician, would make this protocol unreasonably hazardous for the patient.
Pregnant or lactating women, women using hormonal treatment in the 6 months prior to the study.
Women with history of breast disease, previous breast surgery, or breast implants.
Patients with a currently active second malignancy other than non-melanoma skin cancers. Patients are not considered to have a currently active malignancy if they have completed therapy and are free of disease for 3 years.
Psychiatric illness or other conditions and circumstances which could prevent the patient from being compliant with the protocol.
Clareo Health | Metabolic Sodium MRI to Assess Early Response of Breast Cancer to Neoadjuvant Chemotherapy
